| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B | $3.1B | $2.9B | $3.3B | $3.0B | $2.9B | $2.3B | $2.2B |
| Cost of Revenue | $1.7B | $1.8B | $1.7B | $1.7B | $1.6B | $1.5B | $1.2B | $1.1B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B |
| Operating Income | $0.4B | $0.8B | $0.7B | $1.0B | $0.8B | $0.9B | $0.6B | $0.7B |
| Net Income | $0.2B | $0.6B | $0.5B | $0.6B | $0.5B | $0.5B | $0.3B | $0.4B |
| EPS (Basic) | $1.36 | $3.55 | $2.29 | $2.82 | $2.15 | $2.20 | $1.32 | $1.88 |
| EPS (Diluted) | $1.34 | $3.53 | $2.28 | $2.81 | $2.14 | $2.19 | $1.31 | $1.87 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.9B | $7.3B | $7.0B | $7.3B | $6.9B | $6.8B | $7.0B | $5.3B |
| Current Assets | $1.0B | $1.4B | $1.1B | $1.3B | $0.8B | $0.7B | $0.7B | $0.6B |
| Cash & Equivalents | $0.3B | $0.7B | $0.4B | $0.6B | $0.1B | $0.0B | $0.0B | $0.1B |
| Total Liabilities | $3.7B | $4.3B | $4.3B | $4.2B | $4.4B | $4.8B | $5.4B | $3.9B |
| Current Liabilities | $0.4B | $0.5B | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B |
| Stockholders' Equity | $3.2B | $3.0B | $2.7B | $3.1B | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.7B | $0.6B | $0.8B | $0.5B | $0.8B | $0.3B | $0.5B |
| Investing Cash Flow | $-0.0B | $0.0B | $-0.0B | $-0.1B | $-0.1B | $-0.1B | $-1.6B | $-0.4B |
| Capital Expenditures | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.7B | $-0.4B | $-0.7B | $-0.3B | $-0.4B | $-0.7B | $1.2B | $-0.1B |